The role of CA 125 in the evaluation of palpable or enlarged postmenopausal ovaries.
A serum CA 125 assay provided a method of more accurately identifying a postmenopausal woman at high risk for ovarian cancer when a screening ultrasound examination revealed a 2 X 3 cm ovary that could not be detected by palpation.
Schwartz
P E
PE
Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT 06510.
D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000175:diagnosis; D010053:Ovary / Q000473:pathology*; D010173:Palpation; D014463:Ultrasonography
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate